Annotation Detail

Information
Associated Genes
WT1
Associated Variants
WT1 EXON 7 MUTATION
WT1 EXON 7 MUTATION
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
WT1 mutations were associated with an inferior response to induction chemotherapy with a higher rate of resistant disease in young (15-60+, median 45) patients with cytogenetically normal AML.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/139
Gene URL
https://civic.genome.wustl.edu/links/genes/49
Variant URL
https://civic.genome.wustl.edu/links/variants/129
Rating
3
Evidence Type
Predictive
Disease
Acute Myeloid Leukemia
Evidence Direction
Supports
Drug
Cytarabine,Daunorubicin
Evidence Level
B
Clinical Significance
Resistance
Pubmed
18591546
Drugs
Drug NameSensitivitySupported
CytarabineResitance or Non-Reponsetrue
DaunorubicinResitance or Non-Reponsetrue